Novartis India Ltd

Novartis India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Novartis India Ltd

₹ 920 2.29%
21 May 12:26 p.m.
novartis.in BSE: 500672 NSE: NOVARTIND
About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
[1] It imports various medicines to India from different sources across the globe.[2]

Key Points

Business
The company is primarily engaged in the pharmaceutical business in the area of pain management, organ transplantation, neuroscience, etc. [1]

Website BSE NSE
  • Market Cap ₹ 2,272 Cr.
  • Current Price ₹ 920
  • High / Low ₹ 1,248 / 745
  • Stock P/E 22.5
  • Book Value ₹ 318
  • Dividend Yield 2.71 %
  • ROCE 17.0 %
  • ROE 13.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 58.5% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 82.3%

Cons

  • The company has delivered a poor sales growth of -4.06% over past five years.
  • Company has a low return on equity of 12.7% over last 3 years.
  • Earnings include an other income of Rs.42.0 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
98 121 102 80 76 91 79 85 81 92 87 93 84
93 89 85 73 67 73 62 65 70 68 69 67 60
Operating Profit 6 32 16 8 9 17 17 20 11 24 18 26 24
OPM % 6% 26% 16% 10% 12% 19% 21% 23% 14% 26% 21% 28% 29%
-35 27 7 8 16 12 17 22 10 10 10 11 11
Interest 0 0 0 0 0 0 1 0 0 0 0 0 0
Depreciation 1 1 1 1 2 2 1 0 0 1 1 1 1
Profit before tax -31 57 21 14 23 28 32 41 21 34 28 35 34
Tax % -25% 7% 14% 47% -7% 27% 27% 36% 31% 24% 26% 28% 14%
-23 52 18 8 25 20 24 27 15 26 20 25 29
EPS in Rs -9.47 21.21 7.43 3.08 10.13 8.21 9.59 10.76 5.95 10.42 8.27 10.31 11.87
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
859 870 690 656 564 491 438 381 400 379 335 356
861 874 656 631 570 478 426 355 373 314 270 265
Operating Profit -1 -4 34 25 -6 12 12 27 27 65 65 91
OPM % -0% -0% 5% 4% -1% 2% 3% 7% 7% 17% 19% 26%
95 101 207 71 172 78 36 33 -17 58 62 42
Interest 0 0 0 1 6 2 6 8 5 2 1 1
Depreciation 4 4 3 4 3 3 13 12 10 6 3 2
Profit before tax 90 93 237 92 158 86 29 40 -4 115 123 130
Tax % -10% 15% 16% 38% 50% 40% 65% 48% -3% 10% 31% 23%
99 79 198 57 78 52 10 21 -4 103 85 101
EPS in Rs 30.83 24.75 62.04 20.33 31.74 20.97 4.08 8.46 -1.51 41.86 34.50 40.87
Dividend Payout % 32% 40% 16% 49% 32% 48% 245% 118% -663% 113% 72% 61%
Compounded Sales Growth
10 Years: -9%
5 Years: -4%
3 Years: -4%
TTM: 6%
Compounded Profit Growth
10 Years: 3%
5 Years: 58%
3 Years: 35%
TTM: 21%
Stock Price CAGR
10 Years: 4%
5 Years: 10%
3 Years: 15%
1 Year: -17%
Return on Equity
10 Years: 9%
5 Years: 10%
3 Years: 13%
Last Year: 13%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16 16 16 14 12 12 12 12 12 12 12 12
Reserves 945 986 1,178 906 721 747 708 699 679 763 732 773
0 0 0 0 0 0 68 62 24 22 7 5
241 244 239 230 377 223 289 229 242 186 173 158
Total Liabilities 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 925 948
8 8 6 6 5 15 76 64 24 19 7 5
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
1,194 1,238 1,426 1,144 1,106 967 1,001 938 934 964 918 943
Total Assets 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 925 948

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-5 -60 57 -41 161 -194 -23 -69 39 45 113 75
22 719 -630 424 69 274 56 95 87 -153 33 -3
-38 -38 -39 -332 -268 -30 -41 -37 -36 -30 -121 -64
Net Cash Flow -20 622 -612 51 -38 50 -9 -11 90 -139 26 7

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 33 35 27 23 28 34 31 37 41 35 45 41
Inventory Days 96 103 92 104 84 111 117 119 117 99 82 74
Days Payable 100 98 89 87 158 168 145 137 148 108 112 93
Cash Conversion Cycle 29 40 30 40 -45 -23 3 19 10 26 15 22
Working Capital Days 353 6 -35 -14 -99 7 9 75 -18 -33 -57 -43
ROCE % 10% 9% 22% 9% 17% 12% 5% 6% 6% 15% 16% 17%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68%
0.14% 0.17% 0.17% 0.17% 0.23% 0.32% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
0.78% 0.77% 0.77% 0.77% 0.75% 0.52% 0.52% 0.52% 0.52% 0.52% 0.53% 0.53%
28.41% 28.37% 28.37% 28.38% 28.34% 28.47% 28.60% 28.61% 28.60% 28.61% 28.60% 28.61%
No. of Shareholders 43,99643,27542,62241,94743,34343,99243,12841,23939,26539,59638,92639,133

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports